Déficit de 11β-hidroxilasa: mejoría de talla final con hormona de crecimiento y análogos de LHRH

We describe a 7-year-old girl who was referred for pubarche and accelerated skeletal maturation due to 11β-hydroxylase deficiency. Because the patient's predicted height was below her target height, the combination of gonadotropin-releasing hormone analog and growth hormone was added to oral glucocorticoid therapy. With this therapeutic strategy, the patient's predicted height improved significantly and the girl reached a final height in agreement with her target height at the age of 13 years and 6 months.